Combination eye therapy may cut injection frequency for vein occlusion patients
NCT ID NCT01295112
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 25 times
Summary
This study looked at whether adding Ozurdex to standard Avastin eye injections can reduce the number of injections needed for people with a blocked vein in the eye (non-ischemic central retinal vein occlusion). 68 adults participated. The main goal was to count how many Avastin injections were needed over 24 weeks, and also to check vision improvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Texas Retina Associates
Dallas, Texas, 75231, United States
Conditions
Explore the condition pages connected to this study.